OMRF scientists Tim Griffin and Albert Batushansky are pushing the bounds of a decades-old scientific method to study the origins of osteoarthritis.
OMRF researcher Courtney Griffin received a seven-year grant to pursue novel research into blood vessel function and factors that lead to uncontrolled bleeding.
OMRF has entered a license agreement with Shanghai RAAS Blood Products for development of novel hemophilia treatment.
This collaboration is part of GSK’s “Discovery Partnerships with Academia” (DPAc) efforts.
An enzyme called PP1 tells the cells it’s the right time to divide.